evans blue has been researched along with Heart Defects, Congenital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CLAY, RC; ELLIOTT, SR; SCOTT, HW | 1 |
| Badr, AE; Clower, BR; Mychaskiw, G; Tibbs, R; Zhang, JH | 1 |
2 other study(ies) available for evans blue and Heart Defects, Congenital
| Article | Year |
|---|---|
Blood volume in congenital cyanotic heart disease: simultaneous measurements with Evans blue and radioactive phosphorus.
Topics: Blood; Blood Volume; Evans Blue; Heart Defects, Congenital; Heart Diseases; Humans; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary | 1951 |
Optison (FS069) disrupts the blood-brain barrier in rats.
Topics: Albumins; Analysis of Variance; Animals; Blood Pressure; Blood-Brain Barrier; Brain; Capillaries; Carotid Arteries; Cerebrovascular Circulation; Coloring Agents; Contrast Media; Dose-Response Relationship, Drug; Echocardiography; Evans Blue; Fluorocarbons; Gases; Heart Defects, Congenital; Injections, Intra-Arterial; Male; Microspheres; Rats; Rats, Sprague-Dawley | 2000 |